• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Allergan

Allergan

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Actavis set for $20 billion corporate-bond sale

    Actavis set for $20 billion corporate-bond sale

  2. MARKET SNAPSHOT: U.S. Stocks: Futures Climb Ahead Of Data Deluge

    MARKET SNAPSHOT: U.S. Stocks: Futures Climb Ahead Of Data Deluge

  3. UPDATE: U.S. stocks: Futures climb ahead of data deluge

    UPDATE: U.S. stocks: Futures climb ahead of data deluge

  4. Actavis Readies Big Bond Deal

    Actavis Readies Big Bond Deal

  5. Actavis Announces Intention to Adopt "Allergan " Corporate Name

    Actavis Announces Intention to Adopt " Allergan " Corporate Name

  6. Actavis Earnings Soar as Closing of Allergan Deal Looms

    Actavis Earnings Soar as Closing of Allergan Deal Looms

  7. Actavis to Divest U.S. Doryx Rights Before Allergan Deal

    Actavis to Divest U.S. Doryx Rights Before Allergan Deal

  8. Actavis to Divest Itself of U.S. Doryx Rights Ahead of Allergan Deal -- Update

    Actavis to Divest Itself of U.S. Doryx Rights Ahead of Allergan Deal -- Update

  9. Allergan's fourth quarter beats earnings forecasts

    Allergan's fourth quarter beats earnings forecasts

  10. Charting a sluggish, but bullish, S&P 500 -2-

    Charting a sluggish, but bullish, S&P 500 -2-

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.